Struvite Stones

  • John S. Rodman
Chapter
Part of the Topics in Renal Medicine book series (TIRM, volume 5)

Abstract

Stones containing struvite (Mg(NH4)PO4·6H2O) account for approximately 15% of calculi sent to the laboratory for analysis [1]. As the composition of many small, spontaneously passed stones is never determined, this figure certainly overestimates the number of people afflicted with infection-caused stone disease. However, the toll extracted by struvite stone disease from the patient and the medical care system is disproportionately high relative to the small number of patients involved. The tendency for these stones to recur and the morbidity they produce have caused some investigators to refer to them as “stone cancer” [2]. Only children with primary oxalosis may have a more virulent stone disease.

Keywords

Stone Disease Hydroxamic Acid Ureaplasma Urealyticum Urease Inhibitor Jack Bean Urease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Williams, H.E. 1974. Nephrolithiasis. N. Engl. J. Med. 290:33–38.PubMedGoogle Scholar
  2. 2.
    Griffith, D.P. 1978. Struvite stones. Kidney, Int. 13:372–382.Google Scholar
  3. 3.
    Robertson, W.G., Peacock, M. and Nordin, B.E. C. 1968. Activity products in stone-forming and non-stone-forming urine. Clin. Sci. 34:579–594.Google Scholar
  4. 4.
    Andrews, R. K., Blankeley, R.L. and Zerner, B. 1984. Urea and urease. Adv. Inorg. Biochem. 6:245–283.PubMedGoogle Scholar
  5. 5.
    Griffith, D.P., Musher, D.M. and Itin, C. 1976. Urease: the primary cause of infection induced urinary stones. Invest. Urol. 13:346–350.PubMedGoogle Scholar
  6. 6.
    Nielson, I. M. 1956. Urolithiasis in mink: pathology, bacteriology, and experimental production. J. Urol. 75:602–614.Google Scholar
  7. 7.
    Vermeulen, C. W. and Goetz, R. 1954. Experimental urolithiasis IX: influence of infection on stone growth in rats. J. Urol. 72:761–769.PubMedGoogle Scholar
  8. 8.
    Griffith, D.P., Gibson, J.R., Clinton, C.W. et al. 1978. Acetohydroxamic acid: clinical studies of urease inhibitor in patients with staghorn renal calculi. J. Urol. 119:9–15.PubMedGoogle Scholar
  9. 9.
    Grenabo, L., Hedelin, H. and Pettersson, S. 1986. The inhibitory effect of human urine on urease-induced crystallization in vitro. J. Urol. 135:415–419.Google Scholar
  10. 10.
    Hedelin, G.L. and Pettersson, S. The effects of Urease in undiluted human urine. J. Urol., in press.Google Scholar
  11. 11.
    Mandel, N.S., Mandel, G. S. and Haseqawa, A. T. The effect of some urinary stone inhibitors on membrane interaction potentials of stone crystals, in press.Google Scholar
  12. 12.
    Williams, J.J., Rodman, J. S. and Peterson, C.M. 1984. A randomized double-blind study of acetohydroxamic acid in struvite nephrolithiasis. N. Engl. J. Med. 311:760–764.PubMedGoogle Scholar
  13. 13.
    Nemoy, N.J. and Stamey, T. A. 1971. Surgical, bacteriological and biochemical management of infection stones, JAMA 215:1470–1476.PubMedGoogle Scholar
  14. 14.
    Resnick, M.I. 1981. Evaluation and management of infection stones. Urol. Clin. North. Am. 8:265–276.PubMedGoogle Scholar
  15. 15.
    Fowler, J.E., Jr. 1984. Bacteriology of branched renal calculi and accompanying urinary tract infection. J. Urol. 131:213–215.PubMedGoogle Scholar
  16. 16.
    Fowler, J.E., Jr. 1985. Staphylococcus saprophyticus as the cause of infected urinary calculus. Ann. Intern. Med. 102:342–343.PubMedGoogle Scholar
  17. 17.
    Rosenstein, I.J. M. and Hamilton-Miller, J. M.T. 1984. Inhibitors of urease as chemothera-peutic agents. C. R. C. Crit. Rev. Microbiol. 11:1–12.Google Scholar
  18. 18.
    Lewi, H., Hales, D.S.M., Dunsumir, R., Wright, P.A., Sleigh, J. D. and Scott, R. 1984. Netilmicin sulfate prophylaxis in the surgical treatment of renal stones. Surg. Gynecol. Obstet. 159:357–362.PubMedGoogle Scholar
  19. 19.
    Komaroff, A.L. 1986. Urinalysis and urine culture in women with dysuria. Ann. Intern. Med. 104:212–218.PubMedGoogle Scholar
  20. 20.
    Nickel, J.C., Emtage, J. and Costerton, J.W. 1985. Ultrastructural microbal ecology of infection induced urinary stones. J. Urol. 133:622–627.PubMedGoogle Scholar
  21. 21.
    Clerc, M., Texier, J. and Bebear, C. 1984. Experimental production of bladder calculi in rags by Ureaplasma injection. Ann. Microbiol. 125 A:135–140.Google Scholar
  22. 22.
    Takebe, S., Numata, A. and Kobashi, K. 1984. Stone formation by Ureaplasma urealyticum in human urine and its prevention by urease inhibitors. J. Clin. Microbiol. 20:869–873.PubMedGoogle Scholar
  23. 23.
    Furr, P.M., Taylor-Robinson, D. and Hetherington, C.M. 1984. The inhibitory effect of flurofamide on Ureaplasmas and their elimination from marmosets by its use. J. Antimicrob. Chemother. 14:613–618.PubMedGoogle Scholar
  24. 24.
    Kenny, G. E. 1973. Inhibition of the growth of Ureaplasma urealyticum by a new urease inhibitor, flurofamide. Yale J. Biol. Med. 56:172–722.Google Scholar
  25. 25.
    Grenabo, L., Brorson, J.E., Hedelin, H. and Pettersson, S. 1985. Concrement formation in the urinary bladder in rats inoculated with Ureaplasma urealyticum. Urol. Res. 13:195–198.PubMedGoogle Scholar
  26. 26.
    Grenabo, L., Clares, G., Hedelin, H. and Pettersson, S. 1986. Rapidly recurrent renal calculi caused by Ureaplasma urealyticum. a case report. J. Urol. 135:995–997.PubMedGoogle Scholar
  27. 27.
    Pettersson, S., Brorson, J.E., Grenabo, L. and Hedelin, H. 1983. Ureaplasma urealyticum in infection urinary tract stones. Lancet 1:526–527.PubMedGoogle Scholar
  28. 28.
    Grenabo, L., Brorson, J.E., Hedelin, H. and Pettersson, S. 1984. Ureaplasma urealyticum induced crystallization of magnesium ammonium phosphate and calcium phosphates in synthetic urine. J. Urol. 132:795–799.PubMedGoogle Scholar
  29. 29.
    Mitcheson, H. D., Zamenhof, R. G., Bankoff, M. S. and Prien, E. L. 1983. Determination of the chemical composition of urinary calculi by computerized tomography. J. Urol. 130:814–819.PubMedGoogle Scholar
  30. 30.
    Rodman, J.S., Williams, J.J. and Peterson, C.M. 1984. Dissolution of uric acid calculi. J. Urol. 131:1039–1044.PubMedGoogle Scholar
  31. 31.
    Resnick, M.I. and Boyce, W.H. 1980. Bilateral staghorn calculi: patient evaluation and management. J. Urol. 123:338–341.PubMedGoogle Scholar
  32. 32.
    Stewart, A. F., Adler, A., Byers, C. M. et al. 1982. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N. Engl. J. Med. 306:1136–1140.PubMedGoogle Scholar
  33. 33.
    DeVivo, M.J., Fine, P. R., Cutter, G. R. and Maetz, M. H. 1984. The risk of renal calculi in spinal cord injury patients. J. Urol. 131:857–860.PubMedGoogle Scholar
  34. 34.
    Arego, D.E. and Koch, S.J. 1986. Bacteriuria in patients with spinal cord injury. Hosp. Pract. 21:87–114.Google Scholar
  35. 35.
    Nikakhtar, B., Vaziri, N.D., Khonsari, F., Gordon, S. and Mirahmadi. 1981. Urolithiasis in patients with spinal cord injury. Paraplegia 19:363–366.PubMedGoogle Scholar
  36. 36.
    Noe, N.H., Stapleton, F. B., Jerkins, G. R. and Roy, S, III. 1983. Clinical experience with pediatric urolithiasis. J. Urol. 129:1166–1168.PubMedGoogle Scholar
  37. 37.
    Farrell, R.M. and Marshall, V.F. 1974. Urolithiasis in children. Urol. 4:51–56.PubMedGoogle Scholar
  38. 38.
    Brueziere, J. and Roubach, L. 1981. Urinary lithiasis in children. Eur. Urol. 7:134–135.PubMedGoogle Scholar
  39. 39.
    Maclaren, D. M. 1974. The influence of acetohydroxamic acid on experimental Proteus pyelonephritis. Invest. Urol. 12:146–149.PubMedGoogle Scholar
  40. 40.
    Musher, D.M., Griffith, D.P., Yawn, D. et al. 1975. Role of urease in pyelonephritis resulting from urinary tract infection with Proteus. J. Infect. Dis. 131:177–181.PubMedGoogle Scholar
  41. 41.
    Takeuchi, H., Okada, Y. and Yoshida, O. 1982. Treatment of infected urinary stones in rats by a new hydroxamic acid, “N-(pivaroyl)glycinohydroxamic acid”. Urol. Res. 10:217–219.PubMedGoogle Scholar
  42. 42.
    Millner, O.E. Jr., Andersen, A., Appier, M.E., Benjamin, C.E., Edwards, J.G., Humphrey, D.T. and Shearer, E.M. 1982. Flurofamide: a potent inhibitor of bacterial urease with potential clinical utility in the treatment of infection induced urinary stones. J. Urol. 127:346–350.PubMedGoogle Scholar
  43. 43.
    Kobashi, K., Kumaki, K. and Hase, J. 1971. Effect of acyl residues of hydroxamic acids on urease inhibition. Biochem. Biophys. 227:429–441.Google Scholar
  44. 44.
    Fishbein, W.N. and Daly, J.E. 1970. Urease inhibitors for hepatic coma. 11. Comparative efficacy of four lower hydroxamate homologs in vitro and in vivo. Proc. Soc. Exper. Biol. Med. 143:1083–1090.Google Scholar
  45. 45.
    Wang, C. Y. and Lanfong, H. L. 1977. Mutagenicity and antibacterial activity of hydroxamic acids. Antimicrob Agents Chemother II:753–755.Google Scholar
  46. 46.
    Lipczynska-Kochany, E., Iwamura, H., Takahashi, K., Hakura, A. and Kawazoe, Y. 1984. Mutagenicity of pyridine-and-quinoline-carbohydroxamic acid derivatives. Mutat. Res. 135: 139–148.PubMedGoogle Scholar
  47. 47.
    Martell, A., Buli, P. and Brunocilla, E. 1982. Propionohydroxamic acid in infected renal stones. J. Urol. 128:1130–1132.Google Scholar
  48. 48.
    Winston, A., Varaprasad, D.V.P.R., Metterville, J.J. and RRosenkrantz, H. 1985. Evaluation of polymeric hydroxamic acid iron chelators for treatment of iron overloads. J. Pharmacol. Exp. Ther. 232:644–649.PubMedGoogle Scholar
  49. 49.
    Hulcher, F.H. 1982. Isolation and characterization of a new hydroxamic acid from Pseudomonas Mildenbergh. Biochemistry 21:4491–4495.PubMedGoogle Scholar
  50. 50.
    Rodman, J.S., Williams, J.J. and Peterson, C.M. 1983. Partial dissolution of struvite calculus with oral acetohydroxamic acid. Urology 22:410–412.PubMedGoogle Scholar
  51. 51.
    Barcelo, P., Rousaud, A. and Dalet, F. 1983. Acetohydroxamic acid in the treatment of ureogenic lithiasis. Kidney Int. 24:124.Google Scholar
  52. 52.
    Ruiz-Marcellan, F.J., Bernshtam-Ballester, J. and Pinto-Mateos, B. 1983. Tratamiento de las litiasis renal infecciosa con acido acetohidroxamico. Arch. Exp. Urol. 36:354–362.Google Scholar
  53. 53.
    Wolpert, E., Hofmann, A.F. and Summerskill, W.H.J. 1971. Synthesis and metabolism of labeled acetohydroxamic acid a urease inhibitor. Proc. Soc. Exper. Biol. Med. 136:592–596.Google Scholar
  54. 54.
    Putcha, L., Griffith, D.P. and Feldman, S. 1985. Pharmacokinetics of acetohydroxamic acid in patients with staghorn renal calculi. Eur. J. Clin. Pharmacol 28:439–445.PubMedGoogle Scholar
  55. 55.
    Putcha, L., Griffith, D.P. and Feldman, S. 1984. Disposition of 14C-acetohydroxamic acid and 14C-acetamide in the rat. Drug Metab. Dispos. 12:438–443.PubMedGoogle Scholar
  56. 56.
    Burns, J. R. and Gauthier, J. F. 1984. Prevention of urinary catheter incrustations by acetohydroxamic acid. J. Urol. 132:455–456.PubMedGoogle Scholar
  57. 57.
    Burr, R.G. and Nuseibeh, I. 1983. The effect of oral acetohydroxamic acid on urinary saturation in stone-forming spinal cord patients. Brit. J. Urol. 55:162–165.PubMedGoogle Scholar
  58. 58.
    Martelli, A., Buli, P. and Cortecchia, V. 1981. Urease inhibitor therapy in infected renal stones. Eur. Urol. 7:291–293.PubMedGoogle Scholar
  59. 59.
    Buli, P., Brunocilla, E., Tiozzi, E., Platania, A. and Cortecchia, V. 1984. Etude de la cristallurie lors du traitement prophylactique de la lithiase urinaire par l’allopurinol, l’hydro-chlorothiazide, l’oxyde de manganese, les diphosphonates et l’acide proprionohydroxamique. Nephrologie 5:213–216.PubMedGoogle Scholar
  60. 60.
    Andersen, J. A. 1975. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Invest. Urol. 12:381–386.PubMedGoogle Scholar
  61. 61.
    Satoh, M., Munkata, K., Kotoh, K., Seto, N., Kanazawa, T., Takeuchi, H. and Yoshida, O. 1981. Therapy for urolithiasis with hydroxamic acids. IV: Prevention of infected urinary stone formation with N-(Pivaroyl) glycinohydroxamic acid. J. Pharmacol. Biodyn. 4:469–474.Google Scholar
  62. 62.
    Munakata, K., Kobashi, K., Takebe, S. and Hase, J. 1980. Therapy for urolithiasis by hydroxamic acids. III. Urease inhibitory potency and urinary excretion rate of N-Acyl-glycino-hydrixamic acids. J. Pharmacol. Biodyn. 3:451–456.Google Scholar
  63. 63.
    Takeuchi, H., Okada, Y., Kobashi, K. and Yoshida, O. 1982. Treatment of infected urinary stone in rats by a new hydroxamine acid N-(Pivaroyl) glycinohydroxamic acid. Urol. Res. 10:217–219.PubMedGoogle Scholar
  64. 64.
    Javor, A., Frang, D. and Nagy, Z. 1984. Applicability of biosuppressin as an urease-inhibitor. Int. Urol. Nephrol. 16:191–194.PubMedGoogle Scholar
  65. 65.
    Rosenstein, I. 1982, Therapeutic applications of urease inhibitors. J. Antimicrob Chemother 10:159–171.PubMedGoogle Scholar
  66. 66.
    Lewis, L. D., Morris, M.L., Jr. 1984. Treatment and prevention of feline struvite urolithiasis. Vet. Clin. North. Am. 14:649–660.Google Scholar
  67. 67.
    Bohonowych, R. O., Parks, J. L. and Greene, R. W. 1978. Features of cystic calculi in cats in a hospital population. J. Am. Vet. Med. Assoc. 173:301–303.PubMedGoogle Scholar
  68. 68.
    Brown, N.O., Parks, J. L. and Greene, R. W. 1977. Recurrence of canine urolithasis. J. Am. Vet. Med. Assoc. 170:419–422.PubMedGoogle Scholar
  69. 69.
    Brown, N.O., Parks, J.L. and Greene, R.W. 1977. Canine Urolithiasis: Retrospective analysis of 438 cases. J. Am. Vet. Med. Assoc. 170:414–418.PubMedGoogle Scholar
  70. 70.
    Osborne, C. A., Abdulahi, S.U., Leininger, J. R., Polzin, D., Hauer, N.E., Klausner, J. S., Hardy, R. M., Kuzma, A. B. and Gidlund, C.J. 1982. Medical dissolution of canine struvite uroliths. Minn. Vet. 22:14–17.Google Scholar
  71. 71.
    Osborne, C.A., Klausner, J. S., Krawiec, D.R., Griffith, D.P. 1981. Canine struvite urolithiasis: Problems and their dissolution. J. Am. Vet. Med. Assoc. 179:239–244.PubMedGoogle Scholar
  72. 72.
    Vermeulen, C.W., Goetz, R., Ragins, H.D. and Grove, W.J. 1951. Experimental urolithiasis prevention of magnesium ammonium phosphate calculi by reducing the magnesium intake or by feeding an aluminium gel. J. Urol. 66:6–11.PubMedGoogle Scholar
  73. 73.
    Shorr, E. 1945. The possible usefulness of estrogens and aluminium hydroxide gels in the management of renal stones. J. Urol. 53:507–520.Google Scholar
  74. 74.
    Shorr, E. and Carter, A.C. 1950. Aluminium gels in the management of renal phosphatic calculi by the Shorr regimen. JAMA 144:1549–1553.Google Scholar
  75. 75.
    Lavengood, R. W. and Marshall, V. F. 1972. The prevention of urinary phosphatic calculi by the Shorr regimen. J. Urol. 108:363–371.Google Scholar
  76. 76.
    Marshall, V. F. and Green, J. I. 1952. Aluminium gels with constant phosphorus intake for the control of renal phosphatic calculi. J. Urol. 67:614–622.Google Scholar
  77. 77.
    Pyrah, L. N., Paper, F. P. and Smith, I. B. 1956. The use of aluminium hydroxide to prevent renal calculi. Br. J. Urol. 28:231–239.PubMedGoogle Scholar
  78. 78.
    Barrett, G. S. 1951. Influence of aluminium gels on the prevention of urinary calculi. J. Urol. 66:315–330.PubMedGoogle Scholar
  79. 79.
    Slatopolsky, E., Caglar, S., Pennell, J. P. et al. 1971. On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog. J. Clin. Invest. 50:492–499.PubMedGoogle Scholar
  80. 80.
    Licata, A. A., Bou, E., Bartter, F. C. and Cox, J. 1979. Effects of dietary protein on urinary calcium in normal subjects and in patients with nephrolithiasis. Metabolism 28:895–900.PubMedGoogle Scholar
  81. 81.
    Allen, L. H., Oddove, F. A. and Margen, S. 1979. Protein induced hypercalciuria: a longer term study. Am. J. Clin. Nutr. 32:741–749.PubMedGoogle Scholar
  82. 82.
    Arora, B., Selby, P.L., Peacock, M. and Robertson, W. G. 1984. The effect of an increased intake of various constituents of a high animal protein diet on the risk of calcium oxalate stone formation. Urol. Res. 12:56.Google Scholar
  83. 83.
    Tschope, W., Ritz, E. and Schmidt-Gayk, H. 1984. The effects of oral glycine and methionine on urinary lithogenic substances. Urol. Res. 12:61.Google Scholar
  84. 84.
    Smith, L.H., Vandenberg, C.J. and Wilson, D.M. 1978. Nutrition and urolithiasis. N. Engl. J. Med. 298:87–89.PubMedGoogle Scholar
  85. 85.
    Feit, R. M. and Fair, W. R. 1979. The treatment of infection stones with penicillin. J. Urol. 122:592–594.PubMedGoogle Scholar
  86. 86.
    Rodman, J. S. and Williams, J.J. 1985. Adjunctive therapy for struvite stones management. Infections In Surg. 4:867–873.Google Scholar
  87. 87.
    Griffith, D.B., Bragin, S. and Musher, D.M. 1976. Dissolution of struvite urinary stones. Invest. Urol. 13:351–353.PubMedGoogle Scholar
  88. 88.
    Suby, H. I., Suby, R.M. and Albright, F. 1982. Properties of organic acid solutions which determine their irritability to the bladder mucous membrane and the effect of magnesium ions on overcoming this irritability. J. Urol. 48:545–559.Google Scholar
  89. 89.
    Suby, H. I. and Albright, F. 1943. Dissolution of phosphatic urinary calculi by the retrograde introduction of a citrate solution containing magnesium. N. Engl. J. Med. 228:81–91.Google Scholar
  90. 90.
    Dretler, S.P., Pflister, R.C. and Newhouse, J.H. 1979. Renal stone dissolution via percutaneous nephrostomy. N. Engl. J. Med. 300:341–343.PubMedGoogle Scholar
  91. 91.
    Kroon, A., Baadenhuysen, H. and Froeling, P. 1985. Magnesium and citric acid in dissolution of struvite and hydroxy apatite. In Urolithasis and Related Clinical Research. New York and London: Plenum Press, pp. 899–902.Google Scholar
  92. 92.
    Reckler, J., Rodman, J.S., Jacobs, D., Rotterdam, H., Marion, D. and Vaughan, E.D. 1986. Urothelial injury to the rabbit bladder from various alkaline and acidic irrigating solutions. J. Urol. 136:181–183.PubMedGoogle Scholar
  93. 93.
    Mulvaney, W.P. 1959. A new solvent for certain urinary calculi: a preliminary report. J. Urol. 82:546–548.PubMedGoogle Scholar
  94. 94.
    Cunningham, J.J., Friedland, G.W. and Stamey, T.A. 1973. Radiologic changes in the urothelium during Renacidin irrigations. J. Urol. 109:556–558.PubMedGoogle Scholar
  95. 95.
    Blaivas, J. G., Pais, V. M. and Spellman, R. M. 1975. Chemolysis of residual stone fragments after extensive surgery for staghorn calculi. Urology 6:680–686.PubMedGoogle Scholar
  96. 96.
    Cata, A.R. and Tulloch, A.G. S. 1974. Hypermagnesemia in a uremic patient during renal pelvis irrigation with Renacidin. J. Urol. 111:313–314.Google Scholar
  97. 97.
    Auerbach, S., Mainwaring, R. and Schwarz, F. 1963. Renal and ureteral damage following clinical use of Renacidin. J.A.M.A. 183:61–63.PubMedGoogle Scholar
  98. 98.
    Mischol, H. R. and Wildbolz, E. 1971. Instrumental chemolysis of renal calculi: indications and dangers. J. Urol. 105:607–610.PubMedGoogle Scholar
  99. 99.
    Wilson, C., Azmy, A.F., Beattle, T.J. and Murphy A.V. 1986. Hypermagnesemia and progression of renal failure associated with renacidin therapy. Clin. Nephrol. 25:266–276.PubMedGoogle Scholar
  100. 100.
    Russel, M. 1976. Dissolution of renal staghorn calculi with renacidin. J. Urol. 88:141–149.Google Scholar
  101. 101.
    Rodman, J.S., Reckler, J. and Israel, A. 1981. Hemiacidrin irrigations to dissolve stone remnants after nephrolithotomy: problems with solution flow. Urology 18:127–130.PubMedGoogle Scholar
  102. 102.
    Sant, G.R., Blaivas, J.G. and Meares, E. M. 1983. Hemiacidrin irrigation in the management of struvite calculi: long term results. J. Urol. 130:1048–1050.PubMedGoogle Scholar
  103. 103.
    Jacobs, S. C. and Gittes, R. F. 1976. Dissolution of residual renal calculi with hemiacidrin. J. Urol. 115:2–4.PubMedGoogle Scholar
  104. 104.
    Nemoy, N.J. and Stamey, T. A. 1979. Use of hemiacidrin in management of infection stones. J. Urol. 116:2–4Google Scholar
  105. 105.
    Silverman, D.E. and Stamey, T. A. 1983. Management of infections stones: the Stanford experience. Medicine 62:44–51.PubMedGoogle Scholar
  106. 106.
    Brock, W. A., Nachtshein, A. and Parsons, C. L. 1979. Hemiacidrin irrigation of renal pelvic calculi in patients with ileal conduit urinary diversion. J. Urol. 123:345–347.Google Scholar
  107. 107.
    Dretler, S.P. and Pfistere, R. C. 1983. Primary dissolution therapy of struvite calculi. J. Urol. 131:868–863.Google Scholar
  108. 108.
    Resnick, M.I. and Boyce, W.H. 1979. Dissolution versus surgical treatment of nephrolithiasis (letter). N. Engl. J. Med. 300:1488.PubMedGoogle Scholar
  109. 109.
    Krieger, J.N., Rudd, T. G. and Mayo, M. E. 1984. Current treatment of infected stones in high risk patients. J. Urol. 132:874–877.PubMedGoogle Scholar
  110. 110.
    Adams, G.W., Oke, E.J., Dunnick, N. R. and Carson, C.C. 1985. Percutaneous lithotripsy of staghorn calculi. A.J.R. 145:803–807.Google Scholar
  111. 111.
    Kerlan, R.K., Kahn, R.K., Laberge, J. M., Pogany, A.C. and Ring, E.J. 1985. Percutaneous removal of renal staghorn calculi. A.J.R. 145:797–801.Google Scholar
  112. 112.
    Young, A. T., Hulbert, J.C., Cardella, J. F., Hunter, D.W., Castaneda-Zuniga, W.R., Reddy, P. and Amplatz, K. 1985. Percutaneous nephrostolithotomy: application to staghorn calculi. A.J.R. 145:1265–1269.Google Scholar
  113. 113.
    Krieger, J.N., Rudd, T. G. and Mayo, M. E. 1985. Infection stones in patients with myelomingocele and ilean conduit diversion. Arch. Phys. Med. Rehab. 66:360–364.Google Scholar
  114. 114.
    Kahnoski, R.J., Lingeman, J.E., Coury, T.A., Steele, R. E. and Mosbaugh, P.G. 1985. Combined percutaneous and extracorporeal shock wave lithotripsy for staghorn calculi: an alternative to anatrophic nephrolithotomy. J. Urol. 135:679–681.Google Scholar
  115. 115.
    Blandy, J.P. and Singh, M. 1976. The case for a more aggressive approach to staghorn stones. J. Urol. 115:505–506.PubMedGoogle Scholar
  116. 116.
    Vargas, A.D., Bragin, S.D. and Mendez, R. 1982. Staghorn calculus: its clinical presentation, complications and management. J. Urol. 127:860–862.PubMedGoogle Scholar
  117. 117.
    Rous, S.N. and Turner, W.R. 1977. Retrospective study of 95 patients with staghorn calculus disease. J. Urol. 118:902–904.PubMedGoogle Scholar
  118. 118.
    Constantinople, N. L., Waters, W. B. and Yalla, S. V. 1979. Operative versus non-operative management of patients with staghorn calculi and neurogenic bladder. J. Urol. 121:716–718.PubMedGoogle Scholar
  119. 119.
    Stubbs, A.J., Resnick, M.I. and Boyce, W. M. 1978. Anatrophic nephrolithotomy in the solitary kidney. J. Urol. 119:457–460.PubMedGoogle Scholar
  120. 120.
    Mebel, M., Brien, G., Bick, C. et al. 1982. Results of surgical and conservative therapy on patients with nephrolithiasis and chronic renal insufficiency. Eur. Urol. 8:150–154.PubMedGoogle Scholar
  121. 121.
    Martelli, A., Buli, P. and Cortecchia, V. 1981. Acetohydroxamic acid therapy in infected renal stones. Urology 18:320–322.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • John S. Rodman

There are no affiliations available

Personalised recommendations